politics
FDA Advisory Panel Convenes to Review Peptides Amid Growing Wellness Use
Federal health advisers met Thursday to examine more than a half-dozen peptides, substances increasingly popular in wellness circles, despite limited evidence supporting their safety or effectiveness.
Why We Ran This
This story restores the regulatory context behind a fast-moving wellness trend, giving readers who encounter peptide products a more honest frame for the choices they face.
Approved by an editor